Happy Holidays, Lange Neurology Celebrates its Second Year
Happy Holidays, Lange Neurology Celebrates its Second Year  2025 has been a stellar year for Lange Neurology,...
Lange Neurology Joins Phase III Study of Cartesian’s mRNA-Based Cell Therapy
Lange Neurology Joins Phase III Study of Cartesian’s mRNA-Based Cell Therapy  New York, NY— December 17, 2025,...
Lange Neurology Partners With Immunovant on Phase IIB IMVT-1402 Trial
Lange Neurology Partners With Immunovant on Phase IIB IMVT-1402 Trial  New York, NY— December 15, 2025, Lange...
PhenoNet Selects Lange Neurology as Phase IIB ALS Trial Site
PhenoNet Selects Lange Neurology as Phase IIB ALS Trial Site  New York, NY—December 15, 2025, PhenoNet, a...
Lange Neurology Named Phase III Site for Immunovant’s IMVT-1402 Study
Lange Neurology Named Phase III Site for Immunovant’s IMVT-1402 Study  New York, NY—December 11, 2025, Immunovant, Inc.,...
Fostering Collaboration at International ALS/MDN Symposium
Fostering Collaboration at International ALS/MDN Symposium  New York, NY—December 9, 2025, Dr. Dale J. Lange attended the...
Lange Neurology Research Team Attends 2025 Annual NEALS Meeting
Lange Neurology Research TeamAttends 2025 Annual NEALS Meeting  New York, NY—November 1, 2025, Dr. Dale, J. Lange...
Lange Neurology Chosen as Novartis Trial Site in Clinical Trial of VHB937 for ALS
Lange Neurology Chosen As Novartis Trial Site in Clinical Trial of VHB937 for ALS Recruitment for this trial...
Dale J. Lange, MD, Launches Lange Neurology, PC in New York City
Dale J. Lange, MD, Launches Lange Neurology, PC in New York City Bringing Decades of Expertise in Neuromuscular...